GPT and metabolic dysfunction-associated steatotic liver disease: During subgroup analysis, a notable decrease in ALT was observed in participants under 44 years of age, with a baseline serum ALT over 30 IU/L, a BMI below 30 kg/m2, and patients with NAFLD.